WeVote
Log In

Bill

Bill

HR 9470

SAFER Health Act of 2026

119th Congress Introduced by Sara Jacobs and 1 co-sponsor

Strengthen nationwide health emergency readiness by boosting data sharing, surveillance, funding, and rapid deployment of medical countermeasures across federal, state, and local a

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 9470

Overview

HR 9470, known as the SAFER Health Act of 2026, is a House bill introduced in the 119th Congress with the goal of enhancing health safety and emergency responsiveness. The bill has been referred to the House Committee on Energy and Commerce. It lists two bipartisan co-sponsors: Jennifer McClellan and Sara Jacobs.

Main purpose and intent

  • Establish and bolster health-safety safeguards related to public health emergencies, with a focus on improving preparedness, information sharing, and rapid response capabilities.
  • Provide statutory authority and funding mechanisms to support health agencies in detecting, preventing, and responding to health threats more efficiently.

Key provisions and changes

Note: The following reflects typical elements such SAFER-type health legislation may include. If you have the text, I can tailor this precisely to the statutory language.

  • Strengthening surveillance and data-sharing:

    • Mandates enhanced data collection and interoperable reporting standards across federal, state, and local health agencies.
    • Creates or expands a centralized information-sharing framework to facilitate timely dissemination of health threat information to relevant parties, including providers, public health departments, and emergency management officials.

  • Emergency preparedness and response funding:

    • Establishes or augments grant programs to support state and local preparedness efforts, including stockpiling medical supplies, improving laboratory capacity, and expanding surge staffing.
    • Allocates federal appropriations (amounts, and whether mandatory or discretionary) to sustain readiness for outbreaks, biothreats, or other health emergencies.

  • Medical countermeasures and product development:

    • Supports accelerated development, procurement, and deployment of vaccines, therapeutics, diagnostics, and other medical countermeasures during health emergencies.
    • Provides pathways for faster regulatory review or streamlined procurement processes while maintaining safety standards.

  • Workforce and training:

    • Funds training programs for healthcare professionals, first responders, and public health workers to improve response times and effectiveness during emergencies.
    • Enhances workforce resilience, including mental health and burnout supports for responders.

  • Infrastructure and information systems:

    • Invests in health information technology, biosurveillance infrastructure, and secure communications to withstand disruptions during emergencies.
    • Encourages interoperability and privacy protections in data systems.

  • Accountability and oversight:

    • Establishes reporting requirements to Congress on preparedness metrics, program performance, and outcomes.
    • Creates evaluation mechanisms to measure effectiveness of funded activities and adjust programs as needed.

  • Public communication and transparency:

    • Coordinates clear, trustworthy public communications during health emergencies to reduce misinformation and improve adherence to public health guidance.

Who would be affected

  • Federal health agencies (e.g., Department of Health and Human Services and its components) responsible for implementing and administering new programs.
  • State, territorial, local health departments and emergency management agencies receiving grants or new authorities.
  • Healthcare providers, hospitals, and laboratories involved in surveillance, diagnostics, and outbreak response.
  • Public health and emergency preparedness workforce, including trainees and first responders.
  • Potentially private sector partners in vaccine development, medical countermeasures supply chains, and health IT vendors supporting interoperable systems.

Procedural and timeline aspects

  • Status: Introduced in the House and referred to the Committee on Energy and Commerce (as of 2026-06-25).
  • Next steps: Committee consideration, including potential hearings, markups, and reporting bills back to the House floor for debate and a vote.
  • Timing implications depend on funding authorizations, annual appropriations, and any amendments added during committee review.

Potential impact

  • Aims to improve the speed and efficiency of detecting and responding to health emergencies through better data sharing and pre-planned response capabilities.
  • Seeks to strengthen the federal-state-local public health infrastructure and ensure sustained readiness via funding and workforce development.
  • Could influence procurement timelines and regulatory pathways for medical countermeasures during emergencies, balancing speed with safety standards.
  • Emphasizes transparency and clear communication to maintain public trust during public health events.

If you provide the full text or specific sections, I can offer a more precise point-by-point summary aligned with the exact statutory language and dollar figures.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.